Leaflet: Information for the user
Duloxetina Zentiva 30 mg hard gastro-resistant capsules EFG
Duloxetina Zentiva 60 mg hard gastro-resistant capsules EFG
duloxetina
Read this leaflet carefully before you start to take this medicine, because it contains important information for you.
Duloxetina Zentiva contains the active ingredient duloxetina. Duloxetina Zentiva increases the levels of serotonin and noradrenaline in the nervous system.
Duloxetina Zentiva is used in adults to treat:
Duloxetina Zentiva begins to take effect in most people with depression or anxiety within two weeks of starting treatment, but it may take between 2 and 4 weeks to start feeling better. Inform your doctor if you do not notice improvement after this time. Your doctor may continue to give you duloxetina Zentiva when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take several weeks before you start feeling better. Consult your doctor if you do not feel better after 2 months.
Do not take Duloxetine Zentiva if:
Consult your doctor if you have high blood pressure or a heart condition. Your doctor will tell you if you should take Duloxetine Zentiva.
Warnings and precautions
Duloxetine Zentiva may not be suitable for you for the following reasons. Consult your doctor before taking Duloxetine Zentiva if:
Duloxetine Zentiva may cause a feeling of restlessness or inability to sit or stay still. If this happens, tell your doctor.
Some medicines in the same group as Duloxetine Zentiva (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Thoughts of suicide and worsening of depression or anxiety
If you are depressed or have anxiety disorders, you may sometimes have thoughts of self-harm or suicide. These thoughts may be increased when you start taking antidepressant medicines, as these medicines take time to work, usually two weeks but sometimes longer.
You are more likely to have these thoughts if:
Contact your doctor or go directly to the hospital immediately if you have any thoughts of self-harm or suicide.
It may be helpful to tell a close friend or family member that you are depressed or have anxiety disorders, and ask them to read this leaflet. They may be able to tell if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
Children and adolescents under 18 years
Duloxetine Zentiva is usually not used in children and adolescents under 18 years old. You should also know that patients under 18 years old who take this type of medicine have an increased risk of side effects such as suicidal thoughts, suicidal behaviour and hostility (mainly aggression, oppositional behaviour and irritability). Despite this, your doctor may prescribe duloxetine to patients under 18 years old because they decide it may be beneficial for the patient. If your doctor has prescribed duloxetine to a patient under 18 years old and you want to talk about it, please go back to your doctor. You should tell your doctor if any of the symptoms mentioned above appear or get worse in patients under 18 years old who are taking Duloxetine Zentiva. Additionally, in this age group, the long-term safety effects of duloxetine related to growth, maturation and development of cognitive and behavioural functions have not yet been demonstrated.
Taking Duloxetine Zentiva with other medicines
Inform your doctor or pharmacist if you are using, have used recently or may need to take any other medicine.
The main component of Duloxetine Zentiva, duloxetine, is used in other medicines for other treatments: diabetic neuropathic pain, depression, anxiety and urinary incontinence. You should avoid using more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.
Your doctor should decide if you can take Duloxetine Zentiva with other medicines.Do not start or stop taking any medicine, including those bought without a prescription and herbal remedies, without first consulting your doctor.
You should also tell your doctor if you are taking any of the following medicines:
Taking Duloxetine Zentiva with food, drinks and alcohol
Duloxetine Zentiva can be taken with or without food. You should be careful if you take alcohol while taking duloxetine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medicine.
Driving and operating machines
During treatment with Duloxetine Zentiva, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how Duloxetine Zentiva affects you.
Duloxetine Zentiva contains saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. Consult your doctor or pharmacist if you have any doubts.
Duloxetina Zentiva should be taken orally. Swallow the capsule whole with water.
For depression and diabetic neuropathic pain:
The recommended dose of Duloxetina Zentiva is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The initial normal dose of Duloxetina Zentiva is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose may be adjusted to 120 mg per day depending on your response to Duloxetina Zentiva.
To avoid forgetting to take Duloxetina Zentiva, it may be helpful to take it at the same time every day.
Discuss with your doctor for how long you should take Duloxetina Zentiva. Do not stop taking Duloxetina Zentiva, or change your dose without consulting your doctor. It is essential to treat your condition properly to help you improve. If you do not treat it, your condition may not disappear and may become more severe and harder to treat.
If you take more Duloxetina Zentiva than you should:
Call your doctor or pharmacist immediately if you take more Duloxetina Zentiva than prescribed by your doctor. Symptoms of an overdose may include drowsiness, coma, serotonin syndrome (a rare reaction that can cause intense feelings of happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle rigidity), seizures, vomiting, and high heart rate.
If you forgot to take Duloxetina Zentiva:
If you forget to take a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take a single dose as you normally do. Do not take a double dose to make up for the missed doses. Do not take more Duloxetina Zentiva than prescribed for you in a day.
If you interrupt treatment with Duloxetina Zentiva:
DO NOT stop taking your capsules without consulting your doctor, even if you feel better. If your doctor thinks you no longer need to take Duloxetina Zentiva, they will instruct you to reduce your dose for at least 2 weeks before stopping treatment.
Some patients who suddenly stopped treatment with Duloxetina Zentiva have experienced symptoms such as:
These symptoms are usually not significant and disappear within a few days, but if you experience bothersome symptoms, consult your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks.
Very common side effects(may affect more than 1 in 10 patients):
Common side effects(may affect up to 1 in 10 patients):
Children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, the weight increased to similar levels as other children and adolescents of the same age and sex.
Uncommon side effects(may affect up to 1 in 100 patients):
Rare side effects(may affect up to 1 in 1,000 patients):
Very rare side effects(may affect up to 1 in 10,000 patients):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box/blister after CAD. The expiration date is the last day of the month indicated.
Store below 30 °C. Store in the original packaging to protect it from moisture.
Do not dispose of the medication through the drains or in the trash. Ask your pharmacist where to dispose of the unused medication. This will help protect the environment.
What Duloxetina Zentiva contains
The active substance is duloxetine. Each capsule contains hydrochloride equivalent to 30 mg and 60 mg of duloxetine.
The other components are:
Capule content:sucrose; cornstarch; hypromellose; talc; acetate succinate of hypromellose; triethyl citrate.
Capsule coating:
Duloxetina Zentiva 30 mg:
Capsule cap: indigo carmine (E132); titanium dioxide (E171); gelatin.
Capsule body: titanium dioxide (E171); gelatin.
Duloxetina Zentiva 60 mg:
Capsule cap: indigo carmine (E132); titanium dioxide (E171); gelatin. Capsule body: yellow iron oxide (E172);titanium dioxide (E171); gelatin.
What Duloxetina Zentiva looks like and the contents of the pack
Duloxetina Zentiva is a hard, gastro-resistant capsule. Each capsule of Duloxetina Zentiva contains pellets of duloxetine hydrochloride with a coating to protect them from stomach acid.
Duloxetina Zentiva is available in 2 doses: 30 mg and 60 mg.
The 30 mg capsules are hard, opaque gelatin capsules, approximately 15.9 mm in length, with a white opaque body and a light blue opaque cap, containing spherical pellets that are off-white to light yellowish-brown in colour.
The 60 mg capsules are hard, opaque gelatin capsules, approximately 19.4 mm in length, with a cream opaque body and a light blue opaque cap, containing spherical pellets that are off-white to light yellowish-brown in colour.
Duloxetina Zentiva 30 mg is available in packs of 7, 28, 56, 84 and 98 capsules.
Duloxetina Zentiva 60 mg is available in packs of 14, 28, 56, 84 and 98 capsules.
Only some pack sizes may be marketed.
Marketing Authorisation Holder:
Zentiva, k.s.
U Kabelovny 130
102 37 Prague 10
Czech Republic
Responsible for manufacturing:
S.C. Zentiva S.A.
Theodor Pallady Nr 50
032266 Bucharest
Romania
For further information about this medicinal product, please consult the representative of the marketing authorisation holder in your country:
België/Belgique/Belgien Zentiva, k.s. Tél/Tel: +32 (78) 700 112 | Lietuva Zentiva, k.s. Tel: +370 52152025 |
Luxembourg/Luxemburg Zentiva, k.s. Tél/Tel: +352 208 82330 | |
Czech Republic Zentiva, k.s. Tel: +420 267 241 111 | Magyarország Zentiva Pharma Kft. Tel.: +36 1 299 1058 |
Denmark Zentiva Denmark ApS Tlf: +45 787 68 400 | Malta Zentiva, k.s. Tel: +356 2034 1796 |
Germany Zentiva Pharma GmbH Tel: +49 (0) 800 53 53 010 | Netherlands Zentiva, k.s. Tel: +31 202 253 638 |
Estonia Zentiva, k.s. Tel: +372 52 70308 | Norway Zentiva Denmark ApS Tlf: +45 787 68 400 |
Greece Zentiva, k.s. Τηλ: +30 211 198 7510 | Austria Zentiva, k.s. Tel: +43 720 778 877 |
Spain Zentiva Spain S.L.U. Tel: +34 91 111 58 93 | Poland Zentiva Polska Sp. z o.o. Tel: + 48 22 375 92 00 |
France Zentiva France Tél: +33 (0) 800 089 219 | Portugal Zentiva Portugal, Lda Tel: +351210601360 |
Croatia Zentiva d.o.o. Tel: +385 1 6641 830 | Romania ZENTIVA S.A. Tel: +4 021.304.7597 |
Ireland Zentiva, k.s. Tel: +353 818 882 243 | Slovenia Zentiva, k.s. Tel: +386 360 00 408 |
Iceland Zentiva Denmark ApS Sími: +354 539 5025 | Slovakia Zentiva, a.s. Tel: +421 2 3918 3010 |
Italy Zentiva Italia S.r.l. Tel: +39 800081631 | Finland Zentiva Denmark ApS Puh/Tel: +358 942 598 648 |
Cyprus Zentiva, k.s. Τηλ: +30 211 198 7510 | Sweden Zentiva Denmark ApS Tel: +46 840 838 822 |
Latvia Zentiva, k.s. Tel: +371 67893939 | United Kingdom (Northern Ireland) Zentiva, k.s. Tel:+44 (0) 800 090 2408 |
Last update of the summary of product characteristics:
The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.